Third-line Therapy of Multiple Myeloma a Prospective Phase I /II Trial
NCT01010243
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
UNKNOWN
Status
54
Enrollment
OTHER
Sponsor class
Conditions
Multiple Myeloma
Interventions
DRUG:
Lenalidomide, Pioglitazone, dexamethasone, treosulfan
Sponsor
University of Regensburg
Collaborators
[object Object]